GAD1 and gestational diabetes: With increased awareness regarding the subtypes of diabetes in pregnancy and recent findings of impaired insulin secretion in a subset of GDM women, it has been proposed that the most efficient way to discriminate GDM types is to include testing for pancreatic β-cell antibodies, specifically glutamic acid decarboxylase (GAD) antibody in the assessment of abnormal glucose homeostasis in pregnancy (60).